dengu
virus
den
arthropodborn
flavivirus
caus
dengu
fever
df
signific
morbid
mortal
tropic
subtrop
region
world
four
serotyp
dengu
virus
den
type
classic
df
selflimit
ill
character
fever
headach
myalgia
arthralgia
abdomin
pain
sinc
sever
form
diseas
dengu
hemorrhag
fever
dhf
recogn
worldwid
patient
develop
dhf
typic
initi
symptom
similar
df
patient
develop
cytokinestormlik
plasma
leakag
manifest
hemoconcentr
thrombocytopenia
ascit
pleural
effus
near
defever
stage
dhf
pathogenesi
attribut
viral
virul
versu
immun
enhanc
howev
subject
debat
mani
year
innat
immun
system
first
line
host
defens
pathogen
involv
earli
recognit
uptak
microb
host
profession
phagocyt
dendrit
cell
dc
macrophag
germlineencod
receptor
known
pattern
recognit
receptor
prr
prr
recogn
microbi
antigen
initi
innat
immun
respons
follow
adapt
immun
prr
involv
phagocytosi
antigen
present
trigger
intracellular
signal
cytokin
secret
prr
polymorph
may
therefor
affect
viru
entri
replic
immun
among
prr
molecul
also
known
dcsign
dendrit
cellspecif
intercellular
adhes
grab
nonintegrin
play
import
role
earli
interact
pathogen
dendrit
cell
key
role
dct
cell
interact
dc
migrat
pathogen
uptak
dcsign
organ
three
domain
ntermin
domain
locat
cytoplasm
transmembran
domain
anchor
cytoplasm
membran
extracellular
domain
consist
neck
region
form
seven
highli
conserv
amino
acid
repeat
carbohydr
domain
pathogen
bind
gene
locat
chromosom
highli
polymorph
numer
singl
nucleotid
polymorph
snp
report
one
snp
repres
guanin
g
adenin
transit
posit
within
gene
promot
variant
associ
increas
risk
parenter
acquisit
human
immunodefici
viru
hiv
infect
sever
dengu
infect
confer
high
suscept
tuberculosi
south
african
cohort
nevertheless
vannberg
et
al
found
g
variant
allel
associ
protect
tuberculosi
individu
subsaharan
africa
variant
affect
promot
activ
multipl
transcript
factor
bind
site
cacbind
transcript
factor
transfect
studi
vitro
studi
promot
activ
might
reflect
actual
function
associ
aim
test
whether
snp
promot
region
associ
suscept
df
andor
dhf
taiwanes
whether
monocytederiv
dc
human
variou
genotyp
would
reveal
differ
dcsign
membran
express
implic
viral
replic
immun
reaction
den
infect
studi
approv
institut
review
board
irb
chang
gung
memori
hospitalkaohsiung
medic
center
taiwan
dengu
patient
recruit
describ
previous
outbreak
taiwan
larger
retrospect
cohort
design
reapprov
addit
irb
review
document
valid
cell
surfac
express
immun
function
snp
obtain
inform
consent
collect
blood
leukocyt
normal
volunt
aa
ag
genotyp
den
infect
confirm
clinic
dengu
symptom
sign
along
detect
rna
quantit
rtpcr
blood
detect
igm
den
least
increas
denguespecif
hemagglutin
inhibit
titer
convalesc
serum
compar
acutephas
serum
infect
blood
drawn
least
day
subsequ
admiss
hospit
measur
platelet
count
hematocrit
level
chest
xray
abdomin
ultrasonographi
perform
routin
individu
without
evid
hemoconcentr
hypoalbuminemia
refin
differenti
diagnosi
dhf
vs
df
base
pleural
effus
ascit
clinic
diagnosi
dhf
assign
accord
dhf
criteria
world
health
organ
includ
reduc
platelet
count
petechia
hemorrhag
manifest
plasma
leakag
show
hemoconcentr
peak
hematocrit
mean
popul
increas
hematocrit
pleural
effus
ascit
hypoalbuminemia
patient
df
defin
detect
rna
rtpcr
denspecif
igm
without
evid
dhf
primari
secondari
den
infect
identifi
use
previous
establish
serolog
criteria
igmigg
elisa
patient
nondengu
febril
ill
ofi
defin
febril
ill
detect
denspecif
igm
detect
den
rna
obviou
report
bacteri
etiolog
ill
studi
period
popul
control
healthi
unrel
volunt
commun
neither
sign
previou
histori
dengu
infect
den
igg
seroposit
rate
genom
dna
isol
heparinanticoagul
blood
sampl
use
standard
phenolchloroform
extract
follow
alcohol
precipit
genotyp
variant
ag
carri
use
custom
taqman
snp
genotyp
assay
appli
biosystem
foster
citi
ca
usa
primer
sequenc
forward
revers
taqman
minor
groov
binder
probe
sequenc
probe
label
taqman
fluoresc
dye
vic
fam
respect
pcr
conduct
total
volum
use
follow
amplif
protocol
denatur
min
follow
cycl
denatur
follow
anneal
extens
one
minut
pcr
genotyp
sampl
determin
measur
allelespecif
fluoresc
abi
prism
sequenc
detect
system
use
sd
softwar
allel
discrimin
appli
biosystem
valid
genotyp
realtim
pcr
analysi
pcr
product
subject
restrict
fragment
length
polymorph
rflp
analysi
msci
restrict
enzym
new
england
biolab
beverli
usa
show
ident
result
two
genotyp
system
peripher
blood
mononuclear
cell
collect
peripher
blood
healthi
denspecif
igm
igg
seroneg
volunt
aa
ag
genotyp
monocyt
isol
posit
select
accord
manufactur
specif
use
microbead
magnet
cell
separ
mac
miltenyi
biotec
bergisch
gladbach
germani
enrich
cell
puriti
cultur
day
sixwel
plate
complet
rpmi
medium
presenc
ngml
rhgmcsf
ngml
day
half
medium
replac
fresh
medium
supplement
rhgmcsf
express
marker
measur
flow
cytomet
use
specif
antibodi
correspond
isotyp
control
unless
otherwis
state
monocytederiv
dendrit
cell
mddc
infect
multipl
infect
moi
h
cell
wash
twice
remov
cellfre
viru
cultur
complet
rpmi
medium
without
cytokin
densiti
cellsml
plate
cell
supernat
remov
analyz
h
postinfect
neutral
experi
cell
incub
medium
alon
medium
addit
antihuman
antibodi
r
system
minneapoli
mn
usa
min
cell
supernat
harvest
analyz
h
postinfect
total
rna
extract
mddc
subject
quantit
rtpcr
assess
level
mrna
correspond
use
abi
prism
instrument
appli
biosystem
forward
primer
revers
primer
sequenc
detect
respect
pcr
cycl
paramet
cycl
pcr
reaction
one
minut
result
detect
realtim
record
plot
show
fluoresc
vs
time
rtpcr
product
also
visual
ethidium
bromidestain
agaros
pierc
co
rockford
il
usa
gel
bp
ladder
pharmacia
biotech
piscataway
nj
usa
refer
measur
cell
surfac
express
mddc
stain
fitcconjug
mab
specif
dcsign
r
system
minneapoli
mn
usa
isotypematch
fitclabel
control
mous
clone
immunotech
beckman
coulter
fullerton
ca
usa
includ
experi
total
rna
extract
mddc
subject
assess
rna
viral
copi
fluoresc
rtpcr
perform
abi
quantit
pcr
machin
appli
biosystem
cycl
use
taqman
technolog
previous
describ
cytokinechemokin
product
viral
replic
determin
h
postinfect
cellfre
cultur
supernat
macrophag
chemoattract
protein
concentr
measur
use
elisa
kit
ebiosci
inc
san
diego
ca
usa
ifninduc
protein
concentr
measur
use
elisa
kit
r
system
per
manufactur
instruct
data
present
mean
sem
valu
allel
genotyp
distribut
present
number
percentag
conform
allel
frequenc
hardyweinberg
equilibrium
proport
test
compar
observ
expect
frequenc
heterozygot
homozygot
differ
among
patient
den
df
dhf
ofi
popul
control
determin
use
twosid
chisquar
test
fisher
exact
test
odd
ratio
valu
calcul
confid
interv
ci
student
ttest
mannwhitney
u
test
use
statist
comparison
continu
variabl
wilcoxon
signedrank
test
use
statist
comparison
neutral
experi
analys
perform
use
spss
spss
inc
chicago
il
usa
larg
outbreak
southern
taiwan
june
januari
hospitalbas
casecontrol
studi
use
identifi
risk
immun
paramet
employ
decod
dna
sampl
cohort
popul
studi
extend
investig
associ
snp
df
dhf
viral
replic
immun
respons
base
previou
casecontrol
studi
design
includ
dna
sampl
dhf
df
ofi
patient
expand
studi
main
characterist
studi
popul
summar
tabl
signific
differ
sex
total
leukocyt
count
patient
df
dhf
howev
age
year
vs
year
p
serum
got
level
uml
vs
uml
p
gpt
level
uml
vs
uml
p
significantli
higher
dhf
group
tabl
patient
manifest
abdomin
pain
ascit
evidenc
abdomin
ultrasonographi
classifi
df
patient
reveal
thrombocytopenia
petechia
hemorrhag
manifest
admiss
period
investig
associ
snp
promot
region
protect
dengu
infect
suscept
dhf
genom
dna
obtain
den
patient
n
ofi
patient
n
popul
control
n
genotyp
snp
found
ggag
genotyp
den
patient
significantli
higher
ofi
patient
p
popul
control
p
tabl
moreov
ggag
genotyp
significantli
higher
dhf
patient
ofi
patient
popul
control
p
also
significantli
higher
df
patient
p
tabl
analysi
allel
distribut
den
ofi
patient
popul
control
show
g
allel
frequenc
higher
den
patient
compar
ofi
patient
p
popul
control
p
tabl
moreov
frequenc
g
allel
significantli
higher
dhf
patient
ofi
patient
popul
control
p
higher
df
patient
p
tabl
dhf
patient
n
dengu
shock
syndrom
cohort
one
carri
ag
genotyp
investig
whether
snp
promot
region
associ
primari
secondari
den
infect
use
serolog
method
detect
den
antibodi
differenti
primari
secondari
dengu
infect
den
patient
secondari
den
infect
base
detect
viru
rna
den
igg
shown
tabl
secondari
infect
frequent
found
patient
dhf
df
vs
p
found
ggag
genotyp
found
patient
primari
den
infect
patient
secondari
den
infect
reach
significantli
differ
p
shown
tabl
associ
snp
primari
secondari
dengu
infect
df
patient
p
dhf
patient
p
addit
associ
allel
distribut
primari
secondari
dengu
infect
df
dhf
patient
data
shown
due
low
frequenc
gg
genotyp
popul
case
could
recal
patient
data
file
decod
identif
examin
dcsign
express
mrna
level
mddc
protein
level
cell
surfac
healthi
subject
aa
ag
genotyp
quantit
rtpcr
flow
cytometri
respect
signific
increas
mrna
express
detect
mddc
individu
ag
genotyp
individu
aa
genotyp
p
fig
similarli
individu
ag
genotyp
significantli
higher
cell
surfac
dcsign
express
p
fig
howev
surfac
dcsign
express
declin
rapidli
along
infect
mddc
genotyp
subject
show
differ
h
postinfect
fig
investig
whether
snp
correl
viral
replic
measur
rna
copi
mddc
aa
ag
genotyp
h
postinfect
replic
significantli
higher
mddc
individu
aa
genotyp
ag
genotyp
h
postinfect
cell
vs
cell
p
h
postinfect
cell
vs
cell
p
fig
viral
replic
measur
h
postinfect
increas
remark
mddc
moi
p
respect
fig
investig
whether
higher
cell
surfac
dcsign
express
correl
immun
respons
investig
kinet
cytokinechemokin
product
mddc
individu
aa
ag
genotyp
result
show
mddc
ag
genotyp
significantli
higher
product
aa
genotyp
hr
postinfect
pgml
vs
pgml
pgml
vs
pgml
p
respect
fig
product
significantli
increas
mddc
ag
genotyp
aa
genotyp
h
postinfect
p
respect
fig
also
measur
concentr
two
chemokin
implic
recruit
stimul
monocyt
macrophag
dendrit
cell
nk
cell
lymphocyt
found
product
significantli
higher
mddc
ag
genotyp
aa
genotyp
h
postinfect
pgml
vs
pgml
pgml
vs
pgml
pgml
vs
pgml
p
respect
fig
level
peak
hr
subject
genotyp
signific
differ
aa
genotyp
ag
genotyp
pgml
vs
pgml
p
fig
produc
noninfect
bystand
dc
respons
den
infect
potent
chemoattract
activ
nk
cell
modul
adapt
immun
respons
also
known
inhibit
bind
abil
den
immort
cell
mddc
model
cell
individu
ag
genotyp
exhibit
augment
innat
immun
reaction
show
higher
product
postinfect
figur
base
result
hypothes
deninfect
mddc
ag
genotyp
produc
higher
level
might
block
viral
entri
viral
replic
mddc
use
neutral
mab
block
endogen
product
mddc
genotyp
viral
replic
h
post
den
infect
increas
significantli
presenc
neutral
antibodi
absenc
neutral
antibodi
p
respect
fig
product
mddc
individu
ag
genotyp
significantli
decreas
pgml
vs
pgml
p
decreas
mddc
individu
aa
genotyp
pgml
vs
pgml
p
fig
result
suggest
produc
mddc
involv
viral
replic
den
infect
dcsign
shown
import
receptor
den
number
virus
includ
hiv
helicobact
pylori
mycobacterium
tuberculosi
hepat
c
viru
hcv
studi
demonstr
genet
variat
associ
suscept
hiv
mycobacterium
tuberculosi
hcv
dengu
studi
demonstr
snp
involv
viral
replic
immun
respons
first
field
demonstr
relationship
among
function
cell
surfac
express
viral
replic
immun
respons
deninfect
mddc
subject
snp
found
snp
strongli
associ
risk
dhf
vs
df
control
function
studi
determin
mddc
individu
ag
genotyp
significantli
higher
cell
surfac
dcsign
express
aa
genotyp
mddc
ag
genotyp
produc
higher
level
lower
viral
replic
respons
dengu
infect
physiopatholog
variou
manifest
dhf
fulli
understood
sever
studi
support
supposit
secondari
dengu
infect
age
number
preexist
chronic
diseas
diabet
bronchial
asthma
host
genet
factor
increas
risk
progress
dhf
indic
multipl
factor
involv
develop
dhf
find
regard
snp
associ
dhf
vs
ofi
control
p
tabl
casecontrol
associ
studi
suggest
snp
contribut
part
develop
dhf
studi
show
ggag
genotyp
associ
suscept
dhf
compar
df
consist
observ
sakuntabhai
et
al
studi
aa
genotyp
associ
protect
dhf
compar
ofi
popul
control
g
allel
associ
protect
df
sakuntabhai
observ
inconsist
studi
regard
protect
dhf
df
may
result
two
possibl
first
frequenc
g
allel
chines
popul
thailand
second
definit
df
dhf
might
also
differ
defin
df
dhf
accord
criteria
studi
sakuntabhai
et
al
df
defin
criteria
sever
dengu
fever
syndrom
hemorrhag
plasma
leakag
exclud
patient
flulik
symptom
fever
moreov
snp
demonstr
linkag
disequilibrium
three
intron
polymorph
thai
popul
might
also
contribut
suscept
dhf
result
suggest
human
carri
ag
genotyp
higher
dcsign
express
lower
replic
mddc
result
differ
previou
studi
loach
et
al
demonstr
dcsign
express
level
raji
cell
transfect
variou
dcsign
cdna
construct
significantli
correl
infect
rate
dcsign
endocyt
receptor
shown
induc
endocytosi
sever
pathogen
includ
dengu
differ
two
studi
might
due
differ
cell
type
ex
vivo
cultur
system
studi
found
mddc
subject
ag
genotyp
higher
surfac
dcsign
express
higher
product
chemokin
could
limit
replic
fig
howev
higher
surfac
dcsign
express
subject
ag
genotyp
decreas
remark
h
postinfect
fig
studi
loach
et
al
ectop
express
level
dcsign
raji
cell
enhanc
replic
might
relat
higher
quantiti
receptor
lower
product
favor
den
replic
result
studi
suggest
correl
viral
replic
higher
lower
dcsign
express
depend
genet
factor
host
cell
type
dynam
chang
receptor
follow
den
infect
function
studi
snp
determin
mddc
ag
genotyp
higher
dcsign
express
correl
augment
immun
respons
higher
aa
genotyp
product
den
replic
significantli
lower
individu
ag
genotyp
addit
neutral
antibodi
block
product
endogen
significantli
enhanc
replic
fig
suggest
snp
involv
dcsign
express
associ
augment
immun
respons
increas
product
repress
replic
den
support
fact
alter
immun
respons
viral
load
observ
dhf
patient
den
infect
anim
suscept
den
hemorrhag
infect
also
reveal
augment
immun
respons
contrast
interest
note
viral
replic
mddc
individu
aa
genotyp
significantli
higher
individu
ag
genotyp
follow
infect
mechan
snp
influenc
den
replic
mddc
current
unknown
chan
et
al
show
certain
polymorph
lsign
dcsign
homologu
mediat
effici
viral
degrad
sarscov
clinic
implic
screen
genotyp
prevent
den
infect
might
support
differ
viral
load
could
demonstr
among
human
variou
genotyp
futur
outbreak
den
outcom
den
infect
determin
myriad
interact
among
viral
immunolog
human
genet
factor
well
kinet
interact
innat
adapt
immun
studi
provid
new
evid
snp
correl
cell
surfac
express
dendrit
cell
mediat
augment
immun
respons
infect
implic
suscept
dhf
studi
warrant
particularli
regard
genet
variant
dc
polar
adapt
immun
may
promot
protect
develop
dhf
